Chaindrugreview.com

Chain Drug Review. Reporter for the Chain Drug Industry

Never miss Chaindrugreview.com updates: Start reading the news feed of Chain Drug Review right away! This site’s feed is stale or rarely updated (or it might be broken for a reason), but you may check related news or Chaindrugreview.com popular pages instead. It seems that Chain Drug Review is infected or spreading some malware, so we recommend that you stay away until it’s fixed.

News, stories and media buzz related to Chain Drug Review

Subscribe to related news

VIVUS Announces Favorable Markman Ruling in Qsymia(R) Patent Litigation
via kuwaitfinancialexpress

MOUNTAIN VIEW, CA—(Marketwired – July 21, 2016) – VIVUS, Inc. (NASDAQ: VVUS) today announced that the United States District Court for the District of New Jersey has issued a claim construction (Markman) ruling governing patent litigation brought by...
RPT-India generic drugmakers' woes put new focus on quality over price
via forum.smarthealthshop

Wed Mar 26, 2014 7:00am EDT <span id="articleText"/>(Repeats story from Tuesday with no changes to headline, text) <span id="midArticle_0"/>By <a href="http://redirect.viglink.com?key=11fe087258b6fc0532a5ccfc924805c0&u=http%3A%2F...
Billionaire investor Phillip Frost has weak spot for microcaps
via thedealnewsroom.tumblr

Opko Health CEO Phillip Frost is a self-made billionaire and biotech guru with a far flung investment portfolio including a drone company, a cigarette maker, and lots of microcap stocks. By Bill Meagher Dr. Phillip Frost is the CEO of Opko Health Inc...
Takeda Provides Update on Patent Litigation for ACTOS® (pioglitazone HCl) and ACTOplus met® (pioglitazone HCl and metfor...
via tpna

Osaka, Japan, and Deerfield, Ill., April 28, 2010 – Takeda Pharmaceutical Company Limited (“Takeda”) announced today that Takeda and its wholly owned subsidiary, Takeda Pharmaceuticals North America, Inc. (“TPNA”), have completed settlement agreements...
10 Biotech and Specialty Pharma Bargains: Do You Have the Guts to Speculate?
via thetradingreport

There are many investors who believe that the stock market is currently overvalued. To a great extent, they may be correct as there is a lot of excessive valuation to be found in various segments of the market. However, as I believe it is a market of...

Chaindrugreview.com popular pages

CDR – Chain Drug Review - Reporter for the Chain Drug Industry

Reporter for the Chain Drug Industry
Business Archives - CDR – Chain Drug Review

Close

Walgreens to provide free hepatitis C tests

Beginning later this summer, the Chronic Liver Disease Foundation and Walgreens will provide free hepatitis C (HCV) testing at more than 60 of the drug chain's pharmacies in 12 cities across the count...